Biocryst Pharmaceuticals (BCRX) Other Non-Current Liabilities (2011 - 2019)
Biocryst Pharmaceuticals (BCRX) posted Other Non-Current Liabilities of $3.5 million for Q3 2019, down 5.32% on a QoQ basis from $3.7 million in Q2 2019.
Biocryst Pharmaceuticals (BCRX) Other Non-Current Liabilities (2011 - 2019) Analysis & Trends
Biocryst Pharmaceuticals' Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $3.5 million for Q3 2019.
- Quarterly Other Non-Current Liabilities changed N/A year-over-year to $3.5 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $3.5 million (changed N/A YoY) and the FY2018 annual result came in at $2.7 million, changed N/A from the prior year.
- Other Non-Current Liabilities was $3.5 million for Q3 2019 at Biocryst Pharmaceuticals, down from $3.7 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $3.9 million in Q1 2019 and bottomed at $974000.0 in Q2 2016.
- A 3-year average of $2.8 million and a median of $3.1 million in 2018 frame the typical range for Other Non-Current Liabilities.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Biocryst Pharmaceuticals | 2.27 Bn | 2.20 Bn | 151.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 3.54 Mn |
| Jun 30, 2019 | 3.74 Mn |
| Mar 31, 2019 | 3.89 Mn |
| Dec 31, 2018 | 2.70 Mn |
| Sep 30, 2016 | 1.90 Mn |
| Jun 30, 2016 | 974,000.00 |
| Jun 30, 2014 | 2.81 Mn |
| Mar 31, 2014 | 981,000.00 |
| Sep 30, 2013 | 1.58 Mn |
| Jun 30, 2013 | 1.68 Mn |
| Mar 31, 2013 | 2.79 Mn |
| Dec 31, 2012 | 4.75 Mn |
| Sep 30, 2012 | 5.53 Mn |
| Jun 30, 2012 | 4.96 Mn |
| Mar 31, 2012 | 3.96 Mn |
| Dec 31, 2011 | 4.00 Mn |
| Sep 30, 2011 | 2.93 Mn |
| Jun 30, 2011 | 2.34 Mn |